5.3.2 Herpes virus infections

5.3.2.1 Herpes simplex and varicella-zoster infection

Aciclovir
  • Tablets 200mg, 400mg, 800mg (£0.40, £0.42, £0.79 = (price for guide only) 10 tablets)
  • Dispersible tablets 200mg, 400mg, 800mg (£0.40, £2.14, £3.14 = (price for guide only) 10 tablets)
  • Intravenous infusion 250mg/10ml, 500mg/20ml, 1g/40ml (see note 1)

Indications

Notes

  1. For intravenous administration, refer to the manufacturer's Summary of Product Characteristics (SPC) or the BNF for the dose according to indication as the oral and intravenous doses differ

5.3.2.2 Cytomegalovirus

Letermovir
  • Tablets 240mg

Notes

  1. NICE TA591: Letermovir (Prevymis) is recommended as an option for preventing cytomegalovirus (CMV) reactivation and disease after an allogeneic haematopoietic stem cell transplant (HSCT) in adults who are seropositive for CMV (July 2019)

 

Home > Formulary > Chapters > 5. Infections > 5.3 Antiviral drugs > 5.3.2 Herpes virus infections

 

  • First line
  • Second line
  • Specialist
  • Hospital